Gilbert Chu Lab Research

Chu Lab Research

Our laboratory focuses on understanding how cells respond to DNA damage. Our research currently involves three areas that interact with each other: repair of ionizing radiation damage, repair of ultraviolet radiation damage, and transcriptional responses to DNA damage in cancer patients.

To understand how DNA damaged by ultraviolet radiation is recognized and targeted for nucleotide excision repair, we identified and characterized UV-damaged DNA binding activity (UV-DDB). We have shown that DDB2, one of the subunits of UV-DDB, is mutated in xeroderma pigmentosum group E patients. The p48 gene is transcriptionally activated after DNA damage by p53. This activation leads to an increase in global genomic repair and the suppression of UV-induced mutagenesis. Further studies are aimed toward defining how UV-DDB mediates global genomic repair.

To understand how DNA damaged by ionizing radiation is repaired, we have characterized the roles of Ku and DNA-dependent protein kinase (DNA-PK) in the repair of double-strand breaks produced by ionizing radiation or V(D)J recombination. Ku binds to DNA ends and recruits DNA-PK to the site. We determined the structural features on the damaged DNA required for the activation of DNA-PK. This has led to a model for kinase activation based on the electron crystallography structure of DNA-PK. Further studies in cell extracts will determine how the DNA ends are brought together, processed, and rejoined.

We have used microarrays to study transcriptional responses to ionizing radiation in lymphoid cells from cancer patients with adverse reactions to radiation therapy. To interpret the microarray data, we have invented new methods that successfully identified genes whose transcriptional responses predict risk for radiation toxicity. These results provide hope that cancer risk and treatment toxicity will soon be predicted by clinical tests.